Waisman Biomanufacturing
Biotechnology ResearchWisconsin, United States11-50 Employees
Waisman Biomanufacturing is a contract development and manufacturing organization in the biotechnology research industry, located at 1500 Highland Avenue, Madison, Wisconsin 53705, United States. It provides cGMP manufacturing services to biotech companies, researchers, and clinicians developing therapies for clinical trials. Since opening its cGMP facility in 2001, WB has manufactured more than 320 clinical-grade products and has developed platform manufacturing processes and analytical methods to support clinical production of several classes of biotherapeutics, including plasmid DNA, Mesenchymal Stromal Cells, human Embryonic Stem Cells, adenoviral vectors, lentiviral vectors, and AAV. The organization offers support for Investigational New Drug filings, including QA-audited batch records, CMC support, and access to the Type V Facility Master File. WB has engaged in partnerships with industry players, such as a strategic collaboration with RoosterBio in February 2024, and has a track record of collaborations with GigaGen and Heat Biologics on vaccine development. It is described as strategically part of the University of Wisconsin–Madison.
1-888-653-2347 
support@leadiq.com 
